{
  "compound_id": "DB00412",
  "compound_name": "Rosiglitazone",
  "compound_percentile": 0.514705882352941,
  "disease_id": "DOID:11934",
  "disease_name": "head and neck cancer",
  "disease_percentile": 0.463589076723017,
  "metapath_contribution": {
    "CbGbCtD": 0.7571672169542304,
    "CbGpPWpGaD": 0.1390557522173105,
    "CcSEcCtD": 0.10377703082845897
  },
  "n_trials": 1.0,
  "prediction": 0.00133058917658594,
  "status": 0,
  "training_prediction": 0.00161511673203486
}